Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mkaya Mwamburi

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Integrative Molecular Medicine|September 20, 2016
Different associations of premorbid intelligence <i>vs</i>. current cognition with BMI, insulin and diabetes in the homebound elderlyMkaya Mwamburi, Wei Qiao Qiu
The American Journal of Managed Care|November 17, 2017
Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headacheMkaya Mwamburi, Eric J Liebler, Andrew T Tenaglia
The American Journal of Managed Care|November 17, 2017
Cost-effectiveness of gammaCore (non-invasive vagus nerve stimulation) for acute treatment of episodic cluster headacheMkaya Mwamburi, Eric J Liebler, Andrew T Tenaglia
The American Journal of Managed Care|February 29, 2020
Patient experience with non-invasive vagus nerve stimulator: gammaCore patient registryMkaya Mwamburi, Eric J Liebler, Peter S Staats
Environmental Pollution (Barking, Essex : 1987)|March 26, 2015
Medication type modifies inflammatory response to traffic exposure in a population with type 2 diabetesChristine L Rioux, Katherine L Tucker, Doug Brugge, et al.
AIDS Patient Care and Stds|August 30, 2005
Factors associated with wanting to know HIV results in South AfricaD Mkaya Mwamburi, Nozizwe Dladla, Ethel Qwana, et al.
The American Journal of Managed Care|December 14, 2018
Cost-effectiveness of noninvasive vagus nerve stimulation for acute treatment of episodic migraine and role in treatment sequence strategiesMkaya Mwamburi, Andrew T Tenaglia, Eric J Leibler, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 15, 2014
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysisThitima Kongnakorn, James A Sterchele, Christopher G Salvador, et al.
The American Journal of Managed Care|December 14, 2018
Review of evidence on noninvasive vagus nerve stimulation for treatment of migraine: efficacy, safety, and implicationsMkaya Mwamburi, Andrew T Tenaglia, Eric J Leibler, et al.
BMC Ophthalmology|July 13, 2016
Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusionSteven E Bradshaw, Smeet Gala, Merena Nanavaty, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Integrative Molecular Medicine|September 20, 2016
Different associations of premorbid intelligence <i>vs</i>. current cognition with BMI, insulin and diabetes in the homebound elderlyMkaya Mwamburi, Wei Qiao Qiu
The American Journal of Managed Care|November 17, 2017
Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headacheMkaya Mwamburi, Eric J Liebler, Andrew T Tenaglia
The American Journal of Managed Care|November 17, 2017
Cost-effectiveness of gammaCore (non-invasive vagus nerve stimulation) for acute treatment of episodic cluster headacheMkaya Mwamburi, Eric J Liebler, Andrew T Tenaglia
The American Journal of Managed Care|February 29, 2020
Patient experience with non-invasive vagus nerve stimulator: gammaCore patient registryMkaya Mwamburi, Eric J Liebler, Peter S Staats
Environmental Pollution (Barking, Essex : 1987)|March 26, 2015
Medication type modifies inflammatory response to traffic exposure in a population with type 2 diabetesChristine L Rioux, Katherine L Tucker, Doug Brugge, et al.
AIDS Patient Care and Stds|August 30, 2005
Factors associated with wanting to know HIV results in South AfricaD Mkaya Mwamburi, Nozizwe Dladla, Ethel Qwana, et al.
The American Journal of Managed Care|December 14, 2018
Cost-effectiveness of noninvasive vagus nerve stimulation for acute treatment of episodic migraine and role in treatment sequence strategiesMkaya Mwamburi, Andrew T Tenaglia, Eric J Leibler, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 15, 2014
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysisThitima Kongnakorn, James A Sterchele, Christopher G Salvador, et al.
The American Journal of Managed Care|December 14, 2018
Review of evidence on noninvasive vagus nerve stimulation for treatment of migraine: efficacy, safety, and implicationsMkaya Mwamburi, Andrew T Tenaglia, Eric J Leibler, et al.
BMC Ophthalmology|July 13, 2016
Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusionSteven E Bradshaw, Smeet Gala, Merena Nanavaty, et al.
Pageof 7